Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
272 participants
OBSERVATIONAL
2009-04-30
2022-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patient Reported Outcomes in Living Donor Lung Transplantation
NCT00905697
Trajectories of FEV1 After Lung Transplantation
NCT05934617
Diagnostic and Prognostic Biomarkers of Transplant Dysfunction in the Context of Lung Transplantation
NCT04837339
Impact of the Age Difference Between the Donor and Recipient on the Morbidity and Mortality After Lung Transplantation. Study on a National Multicenter Cohort (COLT)
NCT02855372
Identification of Patient Important Outcomes in Lung Transplantation
NCT06066229
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Transplantation
Lung transplantation candidates
Lung transplantation
Lung transplantation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lung transplantation
Lung transplantation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Uncontrolled severe comorbidities
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Health, Labour and Welfare, Japan
OTHER_GOV
Kyoto University, Graduate School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Toru Oga
Respiratory Care and Sleep Control Medicine, Kyoto University, Graduate School of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hiroshi Date, MD, PhD
Role: STUDY_CHAIR
Graduate School of Medicine, Kyoto University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Graduate School of Medicine, Kyoto University
Kyoto, , Japan
Okayama University
Okayama, , Japan
Tohoku University
Sendai, , Japan
Osaka University
Suita, , Japan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E554kyoto
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.